Component
HFCS-42
Formulation containing approximately 42% fructose in its saccharide composition; not 42% of the weight of an arbitrary finished beverage.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
HFCS-42 is a formulation with approximately 42% fructose in its saccharide composition.
Experimental context and source evidence
- dose
- HFCS-42 and HFCS-55; no administered dose
- duration
- Composition reference accessed 2026-09-20
- evidence_access
- Official FDA composition page; not a primary experiment.
- evidence_scope
- literature_reviewed; source-specific curation
- experimental_model
- Official description of HFCS formulations
- exposure_scope
- HFCS identity
- limitations
- Percentages describe sweetener composition, not beverage volume. This source is not a primary metabolic experiment.
- nutrient_topic
- HFCS chapter: actual formulation studies, component biochemistry and interventions are explicitly distinguished. · High-Fructose Corn Syrup / HFCS
- organism
- Official description of HFCS formulations
- plain_language
- HFCS-42 is a formulation with approximately 42% fructose in its saccharide composition.
- primary_references
- [fda-hfcs-composition] High Fructose Corn Syrup Questions and Answers (accessed 2026). https://www.fda.gov/food/food-additives-petitions/high-fructose-corn-syrup-questions-and-answers
- route
- Not an intervention
- tissue
- Ingredient chemistry
High-Fructose Corn Syrup: mechanism of action and metabolic impact (2026-09-20) · lines 17–27
Original AI-assisted curation of twenty primary studies and official FDA composition information, with one reused canonical glucose-transport claim. Study-specific citations, negative findings and limitations retained. Not publisher full text. · supports · Official description of HFCS formulations · source_derived_draft · unverified_draft
## hfcs-form42 HFCS-42 is a formulation with approximately 42% fructose in its saccharide composition. Model/species: Official description of HFCS formulations Tissue: Ingredient chemistry Exposure: HFCS-42 and HFCS-55; no administered dose Route: Not an intervention Duration: Composition reference accessed 2026-09-20 Exposure scope: HFCS identity Limits: Percentages describe sweetener composition, not beverage volume. This source is not a primary metabolic experiment. Reference: [fda-hfcs-composition] High Fructose Corn Syrup Questions and Answers (accessed 2026). https://www.fda.gov/food/food-additives-petitions/high-fructose-corn-syrup-questions-and-answers Access: Official FDA composition page; not a primary experiment.
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.